Beam Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $31,738 | $114,109 | $9,698 | $8,466 |
Gross Profit | 31,738 | 108,441 | -100,071 | -93,292 |
EBITDA | -101,610 | 260,605 | -107,168 | -114,613 |
EBIT | -107,215 | 254,937 | -112,728 | -120,151 |
Net Income | -94,318 | 244,297 | -112,728 | -102,291 |
Net Change In Cash | 31,738 | 114,109 | 9,698 | 8,466 |
Free Cash Flow | -130,745 | -87,023 | -86,490 | -79,586 |
Cash | 288,291 | 294,944 | 267,959 | 282,132 |
Basic Shares | 103,262 | 104,927 | 102,570 | 101,995 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $139,743 | $63,518 | $377,709 | $60,920 |
Gross Profit | 117,449 | -304,043 | 377,709 | -250,674 |
EBITDA | -29,923 | -393,643 | -146,954 | -324,332 |
EBIT | -36,259 | -415,568 | -176,485 | -338,479 |
Net Income | -79,992 | -376,742 | -132,527 | -289,088 |
Net Change In Cash | 139,743 | 63,518 | 377,709 | 60,920 |
Free Cash Flow | -360,048 | -356,192 | -182,927 | -26,424 |
Cash | 294,944 | 281,967 | 435,895 | 232,767 |
Basic Shares | 98,905 | 82,313 | 77,151 | 70,015 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.91 |
2025-12-31 | $2.33 |
2025-09-30 | -$1.10 |
2025-06-30 | -$1 |